Results 111 to 120 of about 6,071 (199)

Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling Study. [PDF]

Pulm Ther
Yarnoff B, Neary MP, Gabriel V, Ghemmouri M, Hodges EN, Tribaldos M, Geurtsen J, Chit A, Beuvelet M, Soudani S, Musci R, Krilov LR.   +11 more
europepmc   +1 more source

Advances in the prevention of respiratory syncytial virus infection in children. [PDF]

J Bras Pneumol
Krey JG, Manfroi L, Damian FB, Pinto LA, Scotta MC.   +4 more
europepmc   +1 more source

Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis. [PDF]

Lancet Reg Health Eur
Perramon-Malavez A, Chiaretti A, Coma E, Craiu M, Foster S, Leonard P, Marlow R, Thors V, Martínez-Marcos M, Mendioroz J, Vila J, Creus-Costa A, Prats C, Roland D, Soriano-Arandes A, Williams TC, Buonsenso D.   +16 more
europepmc   +1 more source

Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study. [PDF]

Eur J Pediatr
Vrentzos D, Pavlopoulou I, Syrogiannopoulos GA, Grivea I, Ladomenou F.   +4 more
europepmc   +1 more source

Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China. [PDF]

Microbiol Spectr
Amjad MN, Wang J, Shen B, Xu H, Ashraf MA, Raza MA, Din Gu, Chen L, Bhutto AA, Yue L, Hussan Hu, Qian D, Dong W, Yan H, Hu Y.   +14 more
europepmc   +1 more source

Recommendations on Respiratory Syncytial Virus (RSV) Immunization Strategies for Infants and Young Children in Countries with Year-Round RSV Activity. [PDF]

Vaccines (Basel)
Cheah FC, Khoo EJ, Ali A, Ismail Z, Awang RA, Ng DC, Chan PWK, Ahmad Kamar A, Chua XY, Sam JI, Abdul Manaf MR, Kassim A.   +11 more
europepmc   +1 more source

Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study. [PDF]

Infect Dis Ther
Yarnoff B, Beuvelet M, Soudani S, Neary MP, Hodges EN, Chit A, Tribaldos M, Gabriel V, Musci R, Geurtsen J, Krilov LR.   +10 more
europepmc   +1 more source

Clesrovimab for the Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants. [PDF]

J Pharm Technol
Phillips B, Jackson C, Phillips J.
europepmc   +1 more source

Broadly neutralizing nanobodies target a defined structural pivot site on the RSV fusion protein. [PDF]

EMBO Mol Med
Wang Q, Ke X, Li E, Hong D, Cheng Z, Li H, Zhang J, Jin T, Gong R, Shu B, Chiu S.   +10 more
europepmc   +1 more source